Lim, Yun-Ping <br/><br/>
The impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese.  [electronic resource] 

 -  BMC immunology  May 2013 
 - 21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2172 
<br/><br/><label>Standard No.: </label>10.1186/1471-2172-14-21  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Asian People--genetics<br/>Drug Therapy, Combination<br/>Female<br/>Gene Frequency--genetics<br/>Genetic Predisposition to Disease<br/>Haplotypes--genetics<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Linkage Disequilibrium--genetics<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Polyethylene Glycols--therapeutic use<br/>Polymorphism, Single Nucleotide--genetics<br/>Recombinant Proteins--therapeutic use<br/>Ribavirin--therapeutic use<br/>STAT6 Transcription Factor--genetics<br/>Taiwan<br/>Treatment Outcome